ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 408

Alpha-Enolase Facilitates Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis

Kichul Shin1, Ji Ah Park2, Seyeon Bae3, Jae Seung Kang3 and Yeong Wook Song4, 1Rheumatology, College of Medicine, Seoul National University, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine,, Seoul National Hospital, Seoul, South Korea, 3Department of Anatomy and Tumor Immunity Medical Research Center, College of Medicine, Seoul National University, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Fibroblasts, inflammation and rheumatoid arthritis, pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Alpha-enolase (ENO1) is a multifunctional glycolytic enzyme ubiquitously expressed in the cytoplasm. Citrullinated ENO1 is reported to be a candidate autoantigen in rheumatoid arthritis (RA), yet its specific biologic function remains unknown. Histologic analysis indicates that ENO1 is expressed in fibroblast-like synoviocytes (FLS), monocytes, and endothelial cells in the synovium. In pro-inflammatory conditions, ENO1 is translocated to the cell surface where it activates plasminogen. Its expression in monocytes mediates migration of the cells into inflamed lung tissues in animal models. Our aim was to investigate the role of surface-expressed ENO1 in RA FLS, the key constituent of pannus in RA synovium.

Methods :

FLS from RA synovial tissues were isolated and cultured in vitro. ENO1 expression on the cell surface was assessed by confocal microscopy. Cell surface-expressed ENO1 was treated with a mouse anti-human ENO1-stimulating monoclonal antibody as well as an isotype control. Scratch test of cultured FLS and transwell experiments under platelet-derived growth factor (PDGF) were performed to assess FLS migration. Cytoskeletal rearrangement was analyzed after staining FLS with an anti-fillagrin antibody. Fluo-4 fluorophore was used for calcium-flux assays directly on discs plated with FLS.

Results :

Cell surface ENO1 expression was low in (5~6 passages) cultured FLS under normal condtions. However, overnight TNF-alpha (as low as 0.1 ng/ml) treatment induced ENO1 translocation to the cell surface, which peaked at 24 hours (figure). Stimulation of cell surface-expressed ENO1 induced faster repopulation of FLS in the scratch test assay, and increased PDGF-induced transwell migration. Cytoplasmic actin filament rearrangement in FLS was markedly enhanced with ENO1 stimulation. Moreover, ENO1 stimulation induced a positive calcium flux response in FLS under intravital confocal microscopy.

Conclusion:

Translocation of cytoplasmic ENO1 to the cell surface in RA FLS is potentiated by TNF-alpha. Our results indicate that ENO1 can contribute to migration of RA FLS, especially under the pro-inflammatory milieu as in the RA synovium.


Disclosure:

K. Shin,
None;

J. A. Park,
None;

S. Bae,
None;

J. S. Kang,
None;

Y. W. Song,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/alpha-enolase-facilitates-migration-of-fibroblast-like-synoviocytes-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology